Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy
Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy
Tumour fraction in circulating free DNA as a biomarker of disease dynamics in metastatic prostate cancer
Management of inflammatory breast cancer
Recommendation guidelines in breast cancer resolution for the Eastern Mediterranean
Expert insight: Managing neutropenia in breast cancer patients
Aspirin: 120 years of innovation, 2017 Scientific Conference, Berlin
The Sanger Institute and personalised genomics
Worrying results from genotyping quality assessments
Focus on screening, not biomarkers
Could personalised medicine increase inequality to medicine access?
Creating a culture of shared data
The Innovative Medicines Initiative